[Brainlife] Methodology

Methodology

Home > Database > Overall Management > Methodology

Contents

Brain Tumors

	Ramsis K. Benjamin,1 Fred H. Hochberg, Elizabeth Fox, Peter M. Bungay, William F. Elmquist, Clinton F. Stewart, James M. Gallo, Jerry M. Collins, Robert P. Pelletier, John F. de Groot, Robert C. Hickner, Idil Cavus, Stuart A. Grossman, and O. Michael Colvin Review of microdialysis in brain tumors, from concept to application: First Annual Carolyn Frye-Halloran Symposium Neuro-Oncology, January 2004, Volume 6, Number 1, Pages: 65 -- 74 (Abstract+)
	Carson BS Sr, Wu Q, Tyler B, Sukay L, Raychaudhuri R, DiMeco F, Clatterbuck RE, Olivi A, Guarnieri M New approach to tumor therapy for inoperable areas of the brain: chronic intraparenchymal drug delivery J Neurooncol 2002 Nov;60(2):151-8
	Guilfoyle MR, Weerakkody RA, Oswal A, Oberg I, Jeffery C, Haynes K, Kullar PJ, Greenberg D, Jefferies SJ, Harris F, Price SJ, Thomson S, Watts C. Implementation of neuro-oncology service reconfiguration in accordance with NICE guidance provides enhanced clinical care for patients with glioblastoma multiforme. Br J Cancer. 2011 May 24. [Epub ahead of print] Abstract \| Reprint \| Related articles
	E. G. Rivarola, G. L. Chantada, L. Ezcurdia, A. Negro, E. Gil Deza, D. Cascallar, D. Santillán, S. Carnaval, E. Morgenfeld, F. G. Gercovich Adherence to standard therapy for the treatment of childhood CNS tumors in Argentina. An audit perspective 40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8573
	Mark L. Rosenblum, Tom Mikkelsen Developing a Brain Tumor Center J Neurooncol, 69(1):169-180, Aug-Sept 2004. (Abstract+)

Clinical Trials

	Anker CJ, Hymas RV, Hazard LJ, Boucher KM, Jensen RL, Shrieve DC. Stereotactic radiosurgery eligibility and selection bias in the treatment of glioblastoma multiforme. J Neurooncol. 2010 Jun;98(2):253-63. Epub 2010 Apr 10. Abstract \| Reprint \| Related articles
	Cook B, Dvorak T. Radiation Oncology/CNS/High grade glioma/Overview Wikibooks. 2008 Abstract
	Franceschi E, Agati R, Brandes AA. End points for Phase II trials in recurrent glioblastoma: the cornerstone for a new era. Expert Rev Anticancer Ther. 2011 Nov;11(11):1713-7. Abstract \| Related articles
	Lang FF, Asher A. Prospective Clinical Trials of Brain Tumor Therapy: The Critical Role of Neurosurgeons J Neurooncol. 2004 Aug-Sep;69(1-3):151-67. Abstract \| Reprint \| Related articles
	Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol. 1990 Jul;8(7):1277-80. Abstract \| Reprint \| Related articles
	Mirimanoff RO, Gorlia T, Mason W, Van den Bent MJ, Kortmann RD, Fisher B, Reni M, Brandes AA, Curschmann J, Villa S, Cairncross G, Allgeier A, Lacombe D, Stupp R. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. J Clin Oncol. 2006 Jun 1;24(16):2563-9. Abstract \| Reprint \| Related articles
	Quant EC, Wen PY. Response Assessment in Neuro-Oncology. Curr Oncol Rep. 2010 Nov 19;. [Epub ahead of print] Abstract \| Related articles
	Wen PY, Schiff D, Cloughesy TF, Reardon DA, Batchelor TT, Chabner BA, Flaherty K, de Groot JF, Gilbert MR, Galanis E, Chang SM, Schwartz GK, Peereboom D, Mehta MP, Yung WK, Grossman SA, Prados MD, Deangelis LM. It Is Time to Include Patients With Brain Tumors in Phase I Trials in Oncology. J Clin Oncol. 2011 Jul 18. [Epub ahead of print] Abstract \| Reprint \| Related articles

Germ Cell Tumors

	Kochi M, Itoyama Y, Shiraishi S, Kitamura I, Marubayashi T, Ushio Y Successful treatment of intracranial nongerminomatous malignant germ cell tumors by administering neoadjuvant chemotherapy and radiotherapy before excision of residual tumors J Neurosurg. 2003 Jul;99(1):106-14

Glioblastoma

	Aldape KD, Wang M, Sulman EP, Hegi M, Colman H, Jones G, Chakravarti A, Mehta MP, Andrews DW, Long L, Diefes K, Heathcock L, Jenkins R, Schultz CJ, Gilbert MR, Radiation Therapy Oncology Group. RTOG 0525: Molecular correlates from a randomized phase III trial of newly diagnosed glioblastoma. J Clin Oncol. 2011 ASCO Annual Meeting Proceedings (Post-Meeting Edition). Vol 29, No 15_suppl (June 20 Supplement), 2011:LBA2000 Abstract
	K. V. Ballman, K. A. Jaeckle, P. D. Brown, P. J. Flynn and J. C. Buckner NCCTG N047D: Relationship between phase II endpoints of 12 month overall survival and 6 month progression-free survival for glioblastoma multiforme (GBM) phase II trials 2005 ASCO Annual Meeting. Orlando, FL. May 13-17. Abstract No. 1508. Journal of Clinical Oncology, Vol 23, No 16S (June 1 Supplement), 2005: 1508
	Brandes AA, Franceschi E, Gorlia T, Wick W, Jacobs AH, Baumert BG, van den Bent M, Weller M, Stupp R. Appropriate end-points for right results in the age of antiangiogenic agents: Future options for phase II trials in patients with recurrent glioblastoma. Eur J Cancer. 2011 Nov 23;. [Epub ahead of print] Abstract \| Related articles
	Markus Bredel, Claudia Bredel, Hannes Vogel, Griffith Harsh IV, Branimir I. Sikic Multiple displacement amplification-based comprehensive genome amplification in fresh-frozen and formalin-fixed/paraffin-embedded clinical brain tumor samples Proceedings of the AACR, Volume 45, March 2004, Abstract Number: 5238.
	Franceschi E, Agati R, Brandes AA. End points for Phase II trials in recurrent glioblastoma: the cornerstone for a new era. Expert Rev Anticancer Ther. 2011 Nov;11(11):1713-7. Abstract \| Related articles
	Hochberg FH, Pruitt A Assumptions in the radiotherapy of glioblastoma Neurology. 1980 Sep; 30(9): 907-11.
	Li J, Wang M, Won M, Shaw EG, Coughlin C, Curran WJ Jr, Mehta MP. Validation and Simplification of the Radiation Therapy Oncology Group Recursive Partitioning Analysis Classification for Glioblastoma. Int J Radiat Oncol Biol Phys. 2010 Oct 1;. [Epub ahead of print] Abstract \| Related articles
	Polley MY, Lamborn KR, Chang SM, Butowski N, Clarke JL, Prados M Six-month progression-free survival as an alternative primary efficacy endpoint to overall survival in newly diagnosed glioblastoma patients receiving temozolomide Neuro Oncol. 2010 Mar;12(3):274-82. Epub 2009 dec 21 Abstract
	Karl F. Schmidt, Mateo Ziu, Nils Ole Schmidt, Pramil Vaghasia, Theresa G. Cargioli, Sameer Doshi, Mitchell S. Albert, Peter McL. Black, Rona S. Carroll, Yanping Sun Volume Reconstruction Techniques Improve the Correlation Between Histological and in vivo Tumor Volume Measurements in Mouse Models of Human Gliomas Journal of Neuro-Oncology, 68 (3): 207-215, July 2004 (Abstract+)

Gliomas

	Corinne Bouvier, Patrice Roll, Benoit Quilichini, Philippe Metellus, Arlette Calisti, Sophie Gilles, Olivier Chinot, Frederic Fina, Pierre M. Martin, Dominique Figarella-Branger Deletions of Chromosomes 1p and 19q are Detectable on Frozen Smears of Gliomas by FISH: Usefulness for Stereotactic Biopsies Journal of Neuro-Oncology, 68 (2): 141-149, June 2004. (Abstract+)
	Brandes AA, Franceschi E. New Agents and New End Points for Recurrent Gliomas. J Clin Oncol. 2011 Jan 31. [Epub ahead of print] Abstract \| Reprint \| Related articles
	Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, Chang CH, Rotman M, Asbell SO, Krisch RE, Nelson DF. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst. 1993 May 5;85(9):704-10. Abstract \| Related articles
	Emmanuelle Di Tomaso, Edward Brown, Yotaro Izumi, Rakesh K. Jain A novel, orthotopic model of glioblastoma growth and invasion for intravital microscopy Proceedings of the AACR, Volume 44, 2nd ed., July 2003, Abstract No. 2956.
	Ferrari M, Cremonesi M, Bartolomei M, Bodei L, Chinol M, Fiorenza M, Tosi G, Paganelli G Dosimetric Model for Locoregional Treatments of Brain Tumors with 90Y-Conjugates: Clinical Application with 90Y-DOTATOC J Nucl Med. 2006 Jan;47(1):105-12.
	A. Flowers Management of malignant gliomas at Hartford Hospital: Patterns of care and outcomes 39th ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No. 464.
	Sophie Godard, Gad Getz, Hiroyuki Kobayashi, Pierre Farmer, Mauro Delorenzi, Annie-Claire Diserens, Marie-France Hamou, Roger Stupp, Robert Janzer, Philipp Bucher, Eytan Domany, Nicolas de Tribolet, Monika E. Hegi Tumor classifier for human gliomas based on gene expression profiles Proceedings of the AACR, Volume 44, 2nd ed., July 2003, Abstract No. 1036.
	Tsugumichi Ichioka, Shin-Ichi Miyatake, Naoki Asai, Yoshinaga Kajimoto, Toshimasa Nakagawa, Hideyuki Hayashi and Toshihiko Kuroiwa Enhanced detection of malignant glioma xenograft by fluorescein-human serum albumin conjugate J Neurooncol. 2004 Mar-Apr;67(1-2):47-52. (Abstract+)
	Lamborn KR, Yung WK, Chang SM, Wen PY, Cloughesy TF, Deangelis LM, Robins HI, Lieberman FS, Fine HA, Fink KL, Junck L, Abrey L, Gilbert MR, Mehta M, Kuhn JG, Aldape KD, Hibberts J, Peterson PM, Prados MD. Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas Neuro Oncol. 2008 Mar 4; [Epub ahead of print] Abstract
	Levin VA, Ictech S, Hess KR. Impact of phase II trials with progression-free survival as end-points on survival-based phase III studies in patients with anaplastic gliomas. BMC Cancer. 2007 Jun 22;7(1):106 [Epub ahead of print] PMID: 17587447 [PubMed - as supplied by publisher]
	Li A, Bozdag S, Kotliarov Y, Fine HA. GliomaPredict: a clinically useful tool for assigning glioma patients to specific molecular subtypes BMC Med Inform Decis Mak. 2010 Jul 15;10(1):38. [Epub ahead of print] Abstract \| Full Text \| Reprint
	Christoph Mamot, John B. Nguyen, Micheal Pourdehnad, Piotr Hadaczek, Ryuta Saito, John R. Bringas, Daryl C. Drummond, Keelung Hong, Dmitri B. Kirpotin, Tracy McKnight, Mitchel S. Berger, John W. Park, Krys S. Bankiewicz Extensive Distribution of Liposomes in Rodent Brains and Brain Tumors Following Convection-Enhanced Delivery Journal of Neuro-Oncology, 68 (1): 1-9, May 2004. (Abstract+)
	Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol. 1990 Jul;8(7):1277-80. Abstract \| Reprint \| Related articles
	Schwartz SA, Weil RJ, Thompson RC, Shyr Y, Moore JH, Toms SA, Johnson MD, Caprioli RM Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry Cancer Res. 2005 Sep 1;65(17):7674-81.
	G. Shah, S. Kesari, R. Xu, J. Henson, T. Batchelor, F. Hochberg, A. Oneill, B. Levy, J. Bradshaw, P. Y. Wen Comparison of 1D, 2D, 3D and volumetric parameters in measuring tumor response in high-grade gliomas in adults 40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1523.
	Smilowitz HM, Weissenberger J, Weis J, Brown JD, O'Neill RJ, Laissue JA. Orthotopic transplantation of v-src-expressing glioma cell lines into immunocompetent mice: establishment of a new transplantable in vivo model for malignant glioma. J Neurosurg. 2007 Apr;106(4):652-9. PMID: 17432718 [PubMed - in process]
	van den Bent MJ, Vogelbaum MA, Wen PY, Macdonald DR, Chang SM End Point Assessment in Gliomas: Novel Treatments Limit Usefulness of Classical Macdonald's Criteria J Clin Oncol. 2009 May 18. [Epub ahead of print] Abstract \| Full Text \| Reprint
	Michael Vavra, M. Jaffer Ali, Eric W.-Y. Kang, Yot Navalitloha, Allison Ebert, Cathleen V. Allen, Dennis R. Groothuis Comparative pharmacokinetics of ¹⁴C-sucrose in RG-2 rat gliomas after intravenous and convection-enhanced delivery Neuro-Oncology, April 2004, Volume 6, Number 2, Pages 104 – 112. (Abstract+)
	Yi-Hong Zhou, Kenneth R. Hess, W. K. Alfred Yung Prognostic model for glioma patients Proceedings of the AACR, Volume 45, March 2004, Abstract Number: 1078.
	Zhao JX, Yang LP, Wang YF, Qin LP, Liu DQ, Bai CX, Nan X, Shi SS, Pei XJ. Gelatinolytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 in rat brain after implantation of 9L rat glioma cells. Eur J Neurol. 2007 May;14(5):510-6. PMID: 17437609 [PubMed - in process]

Medulloblastoma

Risk Stratification
	Packer RJ. Risk Stratification of Medulloblastoma: A Paradigm for Future Childhood Brain Tumor Management Strategies. Curr Neurol Neurosci Rep. 2010 Dec 4;. [Epub ahead of print] Abstract \| Related articles
	Saunders DE, Hayward RD, Phipps KP, Chong WK, Wade AM Surveillance neuroimaging of intracranial medulloblastoma in children: how effective, how often, and for how long? J Neurosurg. 2003 Aug;99(2):280-6.

Meningioma

	Cohen-Inbar O, Sviri GE, Soustiel JF, Zaaroor M. The Geriatric Scoring System (GSS) in meningioma patients-validation. Acta Neurochir (Wien). 2011 May 12;. [Epub ahead of print] Abstract \| Related articles

Metastatic Tumors

	M. T. Carpenter, J. C. Flickinger, M. A. Quader, C. E. Miles Improvements in technique for whole-brain irradiation 40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1539.
	S. Kahl, R. A. Sala, L. Mengelle, M. Alarcón, L. E. Fein Application of the Edmonton Functional Assessment Tool (EFAT) in patients with brain metastases (BM) treated only with palliative radiotherapy (PRT) 40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8054.
	Niwińska A, Murawska M. New Breast Cancer Recursive Partitioning Analysis Prognostic Index in Patients with Newly Diagnosed Brain Metastases. Int J Radiat Oncol Biol Phys. 2011 May 17. [Epub ahead of print] Abstract \| Related articles

Neuroblastoma

	H Rubie, C Coze, D Plantaz, C Munzer, A S Defachelles, C Bergeron, C Thomas, P Chastagner, D Valteau-Couanet, J Michon, V Mosseri and O Hartmann Localised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapy British Journal of Cancer, 3 November 2003, Volume 89, Number 9, 1605-1609.

Non-CNS Tumors

	M. Weyl Ben Arush, M. Haimi, M. Peretz Nahum, H.F. Rennert, K. KatzDelay in diagnosis of children with cancer: a retrospective study of 315 children ECCO 12 - the European Cancer Conference Copenhagen, Denmark, 21-25 September 2003. Abstract No. 640 European Journal of Cancer Supplements; Vol. 1, No. 5, September 2003, page S192.
	P.G. Casali, L. Ciccolallo, R. Capocaccia, P. Bruzzi, L. Licitra, F. Grosso, F. Berrino, G. Gatta A definition of what a rare tumor is ECCO 12 - the European Cancer Conference Copenhagen, Denmark, 21-25 September 2003. Abstract No. 1046 European Journal of Cancer Supplements; Vol. 1, No. 5, September 2003, page S312.
	Miller AB, Hoogstraten B, Staquet M, Winkler A Reporting results of cancer treatment Cancer. 1981 Jan 1; 47(1): 207-14.
	Gary L. Rosner, Walter Stadler, Mark J. Ratain Randomized Discontinuation Design: Application to Cytostatic Antineoplastic Agents Journal of Clinical Oncology, Vol 20, No 22 (November), 2002: 4478-4484.
	Therasse P Measuring the clinical response. What does it mean? Eur J Cancer 2002 Sep;38(14):1817-23.

Pediatric Patients

	Pollack IF. Diagnostic and therapeutic stratification of childhood brain tumors: implications for translational research. J Child Neurol. 2008 Oct;23(10):1179-85. Abstract \| Reprint \| Related articles
	Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P International Classification of Childhood Cancer, third edition Cancer. 2005 Apr 1;103(7):1457-67.

Reporting

	Susan M. Chang, Sharon L. Reynolds, Nicholas Butowski, Kathleen R. Lamborn, Jan C. Buckner, Richard S. Kaplan, and Darell D. Bigner GNOSIS: Guidelines for neuro-oncology: Standards for investigational studies—reporting of phase 1 and phase 2 clinical trials Neuro-oncol 2005; 7(4): 425-434; DOI:10.1215/S1152851705000554 Reprint

Tools

	Pierre Chaurand, Sarah A. Schwartz, Michelle L. Reyzer, and Richard M. Caprioli Imaging Mass Spectrometry: Principles and Potentials Toxicologic Pathology, Jan 2005; vol. 33: pp. 92 - 101 Abstract \| Reprint

	HOME • ARCHIVES OF NEURO-ONCOLOGY • CURRENT NEURO-ONCOLOGY • NEWS • CLINICAL NEURO-ONCOLOGY LIBRARY DATABASE: Classification \| Diagnosis \| Epidemiology \| Etiology & Pathogenesis \| Integrative Medicine \| Overall Management \| Prognosis \| Psychosocial Aspects \| Stem Cells \| Treatment SERVICES: About BrainLife \| Children's Corner \| E-mail Alerts \| Journals \| Links \| Motto, Dedication, etc. \| Patients & Caregivers \| Privacy Policy \| Search \| SiteMap bottom
	This site complies with the HONcode standard for trustworthy health information: verify here